Skip to main content
Top

Breast Cancer Research and Treatment

Issue 1/2007

Content (14 Articles)

Preclinical Study

Legumain expression as a prognostic factor in breast cancer patients

Jessica Gawenda, Frank Traub, Hans J. Lück, Hans Kreipe, Reinhard von Wasielewski

PRE-CLINICAL STUDY

Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer

Geeta Kulkarni, Dmitry A. Turbin, Anahita Amiri, Sujeeve Jeganathan, Miguel A. Andrade-Navarro, Thomas D. Wu, David G. Huntsman, Jonathan M. Lee

Clinical Trial

The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers

P. Kelly Marcom, Claudine Isaacs, Lyndsay Harris, Zee Wang Wong, Aruna Kommarreddy, Nellie Novielli, Gretchen Mann, Yu Tao, Matthew J. Ellis

Clinical Trial

The decision-making experience among women diagnosed with stage I and II breast cancer

Brenda Sabo, Nathalie St-Jacques, Daniel Rayson

Clinical Trial

Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics

Guillermo Carreño, José M. del Casar, Ma Daniela Corte, Luis O. González, Miguel Bongera, Antonio M. Merino, Germán Juan, Raúl Obregón, Enrique Martínez, Francisco J. Vizoso

Clinical Trial

Monitoring primary breast cancer throughout chemotherapy using FDG-PET

Garry M. McDermott, Andrew Welch, Roger T. Staff, Fiona J. Gilbert, Lutz Schweiger, Scott I. K. Semple, Tim A. D. Smith, Andrew W. Hutcheon, Iain D. Miller, Ian C. Smith, Steven D. Heys

Epidemiology

Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women

Martha L. Slattery, Carol Sweeney, Sandra Edwards, Jennifer Herrick, Kathy Baumgartner, Roger Wolff, Maureen Murtaugh, Richard Baumgartner, Anna Giuliano, Tim Byers

EPIDEMIOLOGY

Ultrasound-guided vacuum-assisted core breast biopsy: experience with 406 cases

Enrico Cassano, Linei A. B. D. Urban, Maria Pizzamiglio, Francesca Abbate, Patrick Maisonneuve, Giuseppe Renne, Giuseppe Viale, Massimo Bellomi

Epidemiology

Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer

Heather Greenlee, Yu Chen, Geoffrey C. Kabat, Qiao Wang, Muhammad G. Kibriya, Irina Gurvich, Daniel W. Sepkovic, H. Leon Bradlow, Ruby T. Senie, Regina M. Santella, Habibul Ahsan

Epidemiology

A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland

Cezary Cybulski, Dominika Wokołorczyk, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Bohdan Górski, Tadeusz Dębniak, Bartłomiej Masojć, Anna Jakubowska, Thierry van de Wetering, Steven A. Narod, Jan Lubiński

LETTER TO THE EDITOR

Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: preliminary results

Adriana V Roehe, Ana Paula G Frazzon, Grasiela Agnes, Andrea P Damin, Antonio A Hartman, Marcia S Graudenz

Letter to the Editor

Do nipple aspirate fluid epithelial cells and their morphology predict breast cancer development?

Ferdinando Mannello, Gaetana A. M. Tonti, Wenyi Qin, Weizhu Zhu, Edward R. Sauter

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine